Semafor reports South Africa has Africa's highest adult obesity rate at 30%, yet branded weight loss drugs remain too expensive for most people there.
Recap by typeshit. Post by Semafor on X.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Novo Nordisk is cutting what Wegovy costs in China, Polskie Radio reports. Tap through for the size of the cut and when it takes effect.
The MeAgain medical chief says she avoids compounded GLP-1s because no outcome data exists for them. She suggests asking whether the pharmacy has third-party quality certification.
A look at how peptides taken by mouth can survive the gut and still reach specific sites in the body, a key hurdle for pill versions of these drugs.
Loading…